Report cover image

The Market for Sample Preparation for Next Generation Sequencing (NGS)

Publisher Kalorama Information
Published Apr 27, 2016
Length 185 Pages
SKU # KLI5979660

Description

The Market for Sample Preparation for Next Generation Sequencing (NGS)

The Market for Sample Preparation for Next Generation Sequencing (NGS) covers trends, challenges, strategies, manufacturers, and products, and provides estimates of revenue share and market growth, which includes NGS hardware and consumables. Data presented include NGS sample preparation market and growth rate, 2015-2020; market by geographic region, 2015 (North America, Europe, Asia-Pacific, rest-of-world); market by product type, 2015 (enrichment, libr prep kits panels, etc.; automation/ hardware; nucleic acid extraction; total); and NGS sample preparation leading manufacturer sales and market shares, 2015.

This report notes the direction in which the market for library preparation and target enrichment for NGS is heading, including significant efforts in automation and miniaturization, rapid adoption of smaller sequencers driving applications, and expanding clinical adoption sustaining high growth. Leading manufacturers, such as Agilent Technologies, F. Hoffmann-La Roche AG, Illumina, and Thermo Fisher Scientific, are analyzed, with the competitive situation, deals, and litigation covered in respective chapters.

Table of Contents

185 Pages
    • INTRODUCTION
    • PRODUCT INTRODUCTIONS, INDICATIONS OF PRICE PRESSURE
    • STABILITY IN SEQUENCERS APPEARS TO BE CONTINUING
    • A PERIOD OF RAPID ADOPTION, BUT LOWER PRICES
    • HIGH LIKELIHOOD OF LONGER-TERM CHALLENGES
    • GROWTH -- BUT COMPETITIVE, CONCENTRATED, AND UNPREDICTABLE
    • BACKGROUND
    • SCOPE AND METHODOLOGY
    • APPLICATIONS AND DEFINITIONS
    • SIGNIFICANT EFFORTS IN AUTOMATION, MINIATURIZATION
    • MERGERS, ACQUISITIONS, EQUITY INVESTMENTS INCREASING
    • RAPID ADOPTION OF SMALLER SEQUENCERS DRIVING APPLICATIONS
    • EXPECTED SEQUENCER PLATFORMS STALLED OR CANCELLED
    • STABILITY DESPITE POSSIBILITY OF DISRUPTIVE TECHNOLOGIES
    • SEQUENCER UNIT SALES CONTINUEMOMENTUM
    • EXPANDING CLINICAL ADOPTION SUSTAINS HIGH GROWTH
    • CHINA BECOMING MAJOR PLAYER IN MARKET
    • DISTRIBUTION DEALS INCREASE AS SMALLER COMPANIES ENTER MARKET
    • REGULATORY SITUATION UNCLEAR BUT EVOLVING SOMEWHAT
    • DNA Extraction, Purification, and Isolation Products
    • RNA Extraction, Purification, and Isolation Products
    • Panels, Exome Kits, and Other Target Enrichment Products
    • DNA Library Construction/ Preparation Products
    • RNA-Seq, Transcriptome, and Gene Expression Products
    • Small RNA NGS Sample Preparation Products
    • ChIP-Seq Products
    • Methylation and Other Epigenetics Products
    • Single-Cell NGS Products
    • Synthetic/ Novel Long Read NGS Technologies/ Products
    • Library Quantitation / Quality Control Products
    • Shearing and Fragmentation Products
    • Fragment/ Size Selection Products
    • Automated Systems, Liquid Handlers, Other Hardware
    • RECENT PRODUCT INTRODUCTIONS
    • REVENUES FORECAST
    • REVENUES BY REGION
    • REVENUES BY PRODUCT TYPE
    • ILLUMINA CONSUMABLES REVENUES
    • INTRODUCTION
    • RELATIVE STABILITY IN SEQUENCER PLATFORMS
    • NGS SAMPLE PREPARATION MARKET SHARES
    • SMALLER COMPANIES EXPERIENCING MIXED SUCCESS
    • SEQUENOM, SEVERAL NIPT COMPANIES FIGHTING
    • ILLUMINA'S CONFLICTS WITH OXFORD NANOPORE
    • ENZO BIOCHEM BRINGS SUIT AGAINST NUMEROUS COMPANIES
    • 454 (ROCHE) SUES ION TORRENT (THERMO FISHER)
    • RAINDANCE TECHNOLOGIES SUES 10X GENOMICS
    • 10X GENOMICS' DISPUTE WITH BIO-RAD
    • SEQUENOM SHAREHOLDER SUES OVER PRICE "CAPPING"
    • CLASS ACTION SHAREHOLDER LAWSUIT FILED AGAINST PACIFIC BIOSCIENCES
    • HELICOS' PATENT INFRINGEMENT SUIT AGAINST PACBIO, LIFE TECHNOLOGIES, AND ILLUMINA
    • ILLUMINA'S TWO LAWSUITS AGAINST COMPLETE GENOMICS FOR INFRINGEMENT
    • LIFE TECHNOLOGIES AND ILLUMINA DISPUTE OVER AMPLIFICATION ON SOLID SURFACES
    • LIFE TECHNOLOGIES FILES INFRINGEMENT SUIT AGAINST PROMEGA
    • ENZO BIOCHEM DISPUTES SEQUENCING PATENTS
    • AZCO BIOTECH SUES QIAGEN AND INTELLIGENT BIO-SYSTEMS
    • INTELLIGENT BIO-SYSTEMS (QIAGEN) AND COLUMBIA UNIVERSITY SUE ILLUMINA FOR INFRINGEMENT
    • LABCORP'S ESOTERIX SUES LIFE TECHNOLOGIES
    • GENETIC TECHNOLOGIES SUES SEVERAL FIRMS FOR INFRINGEMENT OF HAPLOTYPE DETERMINATION TECHNIQUE
    • ILLUMINA SUES LIFE TECHNOLOGIES OVER ION TORRENT SYSTEMS
    • AFFYMETRIX DISMISSES SUIT AGAINST PACIFIC BIOSCIENCES AND FORMER EMPLOYEES
    • LIFE TECHNOLOGIES DEFEATS VISIGEN STAKEHOLDERS AFTER ARBITRATION
    • CATALYST ASSETS SUES LIFE TECHNOLOGIES FOR INFRINGEMENT
    • PATENT INTERFERENCE BETWEEN LIFE TECHNOLOGIES AND PACIFIC BIOSCIENCES
    • LADATECH SUES ILLUMINA OVER DNA AMPLIFICATION PATENT
    • ILLUMINA FILES `841 PATENT INFRINGEMENT SUIT AGAINST AFFYMETRIX
    • AFFYMETRIX AND ILLUMINA SETTLE CASE OVER `243, `432, `531, `365, AND `716
    • APPLIED BIOSYSTEMS AND ILLUMINA CLAIMS AND COUNTER-CLAIMS OVER SEQUENCING-BY-LIGATION BOTH UNSUCCESSFUL
    • Significant Collaborations in Recent Years
    • 10X GENOMICS
    • AGILENT TECHNOLOGIES
    • F. HOFFMANN-LA ROCHE AG
    • FLUIDIGM
    • ILLUMINA
    • NEW ENGLAND BIOLABS
    • OXFORD NANOPORE
    • PACIFIC BIOSCIENCES
    • QIAGEN
    • THERMO FISHER SCIENTIFIC
    • CHALLENGES
    • STRATEGIC RECOMMENDATIONS

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us